Aradigm Corporation Share Price Nasdaq
Equities
US0385054004
Biotechnology & Medical Research
Sales 2016 | 195K 16.28M | Sales 2017 | 14.46M 1.21B | Capitalization | 97.3M 8.12B |
---|---|---|---|---|---|
Net income 2016 | -32M -2.67B | Net income 2017 | -10M -835M | EV / Sales 2016 | 73.3 x |
Net cash position 2016 | 9.37M 782M | Net Debt 2017 | 7.91M 660M | EV / Sales 2017 | 7.27 x |
P/E ratio 2016 |
-0.72
x | P/E ratio 2017 |
-9.3
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 60.28% |
1st Jan change | Capi. | |
---|---|---|
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |